Account

The Medical and Surgical Practice of NaProTECHNOLOGY, 677-696, 2004

Chapter 51: Effectiveness of NaProTECHNOLOGY

Thomas W Hilgers

Author affiliations
  • Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR
Read at source

Abstract

Cumulative pregnancy and live birth data from the Pope Paul VI Institute document NaProTECHNOLOGY outcomes across diagnostic categories including unexplained infertility, endometriosis, PCOD, and tubal disease, with multi-year follow-up that captures pregnancies occurring after continued treatment — a metric not captured in per-cycle ART statistics. These outcomes provide the evidence base for positioning NaProTECHNOLOGY as a first-line rather than last-resort reproductive medicine strategy.

Topics

RRM Methods > NaProTECHNOLOGY > Clinical OutcomesRRM Methods > NaProTECHNOLOGY > EffectivenessRRM Methods > General FABM > ComparisonRRM Methods > Billings > Clinical OutcomesDiagnostics > Cycle Charting > Clinical UtilityDiagnostics > Biomarker Monitoring > Cervical MucusDiagnostics > Hormone Assays > ProgesteroneDiagnostics > Ultrasound > Follicular MonitoringDiagnostics > Semen Analysis > Standard ParametersInfertility > Female Factor > Ovulatory DysfunctionInfertility > Female Factor > Endometriosis-RelatedInfertility > Female Factor > Tubal FactorInfertility > Female Factor > UnexplainedInfertility > Female Factor > Age-RelatedInfertility > Male Factor > OligospermiaEndometriosis > Excision Surgery > OutcomesEndometriosis > Staging > Severity AssessmentPCOS > Treatment > SurgicalPCOS > Treatment > PharmacologicalReproductive Endocrinology > Ovulation > PhysiologyReproductive Endocrinology > Luteal Phase > DeficiencyReproductive Endocrinology > Progesterone > SupplementationMenstrual Cycle > Biomarkers > Cervical MucusMenstrual Cycle > Disorders > AmenorrheaMenstrual Cycle > Cycle Charting > Clinical ApplicationSurgery > Excision > OutcomesSurgery > Microsurgery > TubalSurgery > Adhesion Prevention > BarriersPregnancy > Outcomes > Live BirthPregnancy > Outcomes > Miscarriage RatesAndrology > Semen Analysis > Reference ValuesContraception/Comparison > FABM vs Hormonal > EffectivenessGeneral OB/GYN > Epidemiology > TrendsGeneral OB/GYN > Clinical Practice > Standards
naprotechnology pregnancy success rates, how successful is naprotechnology for infertility, naprotechnology vs ivf effectiveness comparison, natural fertility treatment success statistics, endometriosis surgery pregnancy rates without ivf, pcos pregnancy success natural treatment, infertility treatment outcomes kaplan meier curves, per woman pregnancy rate calculation infertility, fecundability rate fertility treatment comparison, ivf dropout discontinuation rates, multiple pregnancy rates naprotechnology vs ivf, tubal occlusion surgery pregnancy outcomes, oligospermia natural treatment success, dry mucus cycle pregnancy difficulty, limited mucus cycle fertility outcomes, cumulus oophorus ovulation treatment, luteal phase deficiency treatment pregnancy rates, luteinized unruptured follicle syndrome pregnancy, endometriosis stage iv pregnancy success surgical treatment, hypothalamic amenorrhea pregnancy success rate, ovarian wedge resection polycystic ovaries outcomes, age related infertility success rates over 38, creighton model system pregnancy without treatment, fertility focused intercourse timing success, adoption after failed fertility treatment family building, proximal tubal occlusion repair pregnancy outcomes, severe pelvic adhesions goretex barrier pregnancy, tubal reimplantation prolene stent outcomes, cycle by cycle ivf success rate limitations

Cite this article

Hilgers, T. W. (2004). Chapter 51: Effectiveness of NaProTECHNOLOGY. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 677-696.

Related articles

Chapter 49: Family Physician's Approach
Hilgers TW et al. 2004 The Medical and Surgical Practice of NaProTECHNOLOGY

Family physicians are optimally positioned to introduce NaProTECHNOLOGY to patients presenting with infertility, irregular cycles, or recurrent pregnancy loss during routine primary care, enabling ear...

Clinical OutcomesProtocolEffectiveness

Chapter 50: Pregnancy Following Failed ART
Hilgers TW et al. 2004 The Medical and Surgical Practice of NaProTECHNOLOGY

Patients who have undergone multiple failed IVF cycles and are counseled to abandon fertility treatment represent a significant NaProTECHNOLOGY cohort in whom undiagnosed correctable pathology — inclu...

Clinical OutcomesEffectivenessProtocol

Chapter 83: Family Physician's Experience
Hilgers TW et al. 2004 The Medical and Surgical Practice of NaProTECHNOLOGY

Family physicians trained in NaProTECHNOLOGY serve as primary coordinators of medical management — prescribing targeted hormone support, monitoring biomarker trends, and triaging surgical referrals — ...

Clinical OutcomesEffectivenessProtocol

Chapter 84: Role of FertilityCare Practitioner
Hilgers TW et al. 2004 The Medical and Surgical Practice of NaProTECHNOLOGY

The FertilityCare Practitioner (FCP) is the trained educator and coach who teaches the Creighton Model FertilityCare System to clients, standardizes charting methodology, and serves as the primary dat...

ProtocolTeachingClinical Outcomes

Learn

Resources

Tools

Help

Candid Platinum Transparency 2026

RRM Academy is a 501(c)(3) nonprofit providing free and low-cost education in restorative reproductive medicine for patients and healthcare professionals.

This site is an educational resource and does not provide medical advice. Inclusion of a study does not imply endorsement of its findings. Always consult a qualified healthcare provider for diagnosis and treatment.

© 2026 RRM Academy · All Rights Reserved

Restorative Reproductive Medicine Foundation Inc. · 3401 Hartzdale Dr, Ste 103B PMB 3518, Camp Hill, PA 17011 · EIN: 93-4594315
Terms of Use Medical Disclaimer Privacy Policy